scispace - formally typeset
M

Michele Bortolomeazzi

Researcher at King's College London

Publications -  12
Citations -  499

Michele Bortolomeazzi is an academic researcher from King's College London. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 3, co-authored 7 publications receiving 208 citations. Previous affiliations of Michele Bortolomeazzi include Francis Crick Institute.

Papers
More filters
Journal ArticleDOI

The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens

TL;DR: The Network of Cancer Genes is a manually curated repository of 2372 genes whose somatic modifications have known or predicted cancer driver roles, and annotates properties of cancer genes, such as duplicability, evolutionary origin, RNA and protein expression, miRNA and protein interactions, and protein function and essentiality.
Posted ContentDOI

The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens

TL;DR: The Network of Cancer Genes is a manually curated repository of 2,372 genes whose somatic modifications have a known or predicted cancer driver role, and annotates properties of cancer genes, such as duplicability, evolutionary origin, RNA and protein expression, miRNA and protein interactions, protein function and essentiality.
Journal ArticleDOI

Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource

TL;DR: In this paper , the authors collected a literature-based repertoire of 3355 well-known or predicted drivers of cancer and non-cancer somatic evolution in 122 cancer types and 12 noncancer tissues.
Journal ArticleDOI

Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource

TL;DR: In this paper , the authors collected a literature-based repertoire of 3355 well-known or predicted drivers of cancer and non-cancer somatic evolution in 122 cancer types and 12 noncancer tissues.